BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17054240)

  • 1. Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults.
    Holdgate A; Foo A
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005154. PubMed ID: 17054240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal etripamil for rapid treatment of paroxysmal supraventricular tachycardia.
    Calvert P; Gupta D
    Future Cardiol; 2024; 20(3):163-170. PubMed ID: 38717391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of supraventricular tachycardias.
    Bibas L; Levi M; Essebag V
    CMAJ; 2016 Dec; 188(17-18):E466-E473. PubMed ID: 27777258
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined modified Valsalva maneuver with adenosine supraventricular tachycardia: A comparative study.
    Xiao L; Ou X; Liu W; Lin X; Peng L; Qiu S; Zhang Q
    Am J Emerg Med; 2024 Apr; 78():157-162. PubMed ID: 38281376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torsades de pointes and myocardial infarction following reversal of supraventricular tachycardia with adenosine: a case report.
    Paixão MR; Ribas FF; Accorsi TAD; Amicis K; Souza JL
    Einstein (Sao Paulo); 2024; 22():eRC0522. PubMed ID: 38597464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CALCIUM CHANNEL BLOCKERS SHOULD BE FIRST-LINE TREATMENT FOR HEMODYNAMICALLY STABLE SUPRAVENTRICULAR TACHYCARDIA.
    Rech MA; Gottlieb M
    Ann Emerg Med; 2024 Apr; 83(4):394-395. PubMed ID: 38127021
    [No Abstract]   [Full Text] [Related]  

  • 7. WITHDRAWN: Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults.
    Holdgate A; Foo A
    Cochrane Database Syst Rev; 2012 Feb; (2):CD005154. PubMed ID: 22336809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis.
    Delaney B; Loy J; Kelly AM
    Eur J Emerg Med; 2011 Jun; 18(3):148-52. PubMed ID: 20926952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
    Lim SH; Anantharaman V; Teo WS; Chan YH
    Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
    DiMarco JP; Miles W; Akhtar M; Milstein S; Sharma AD; Platia E; McGovern B; Scheinman MM; Govier WC
    Ann Intern Med; 1990 Jul; 113(2):104-10. PubMed ID: 2193560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative Treatment Options for Atrioventricular-Nodal-Reentry Tachycardia: An Emergency Medicine Review.
    Brubaker S; Long B; Koyfman A
    J Emerg Med; 2018 Feb; 54(2):198-206. PubMed ID: 29239759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.
    Alabed S; Sabouni A; Providencia R; Atallah E; Qintar M; Chico TJ
    Emergencias; 2020 Feb; 32(1):57-58. PubMed ID: 31909914
    [No Abstract]   [Full Text] [Related]  

  • 13. In The Line of Treatment: A Systematic Review of Paroxysmal Supraventricular Tachycardia.
    Ahmad F; Abu Sneineh M; Patel RS; Rohit Reddy S; Llukmani A; Hashim A; Haddad DR; Gordon DK
    Cureus; 2021 Jun; 13(6):e15502. PubMed ID: 34268033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of left accessory cardiac pathway conduction disorders using radiofrequency catheter ablation under the guidance of the Ensite NavX 3D mapping system: a retrospective study.
    Dengke Z; Lan L; Xiangli S; Shubin J
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):387-392. PubMed ID: 30178222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valsalva maneuver using a Handmade Device in Supraventricular Tachycardia Reversion; a Quasi Experimental Study.
    Motamedi M; Akbarzadeh MA; Safari S; Shahhoseini M
    Emerg (Tehran); 2017; 5(1):e81. PubMed ID: 29201963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China.
    Wang L; Li M; Xie J; Cao Y; Liu H; He Y
    Sci Rep; 2017 Oct; 7(1):13819. PubMed ID: 29061976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.
    Alabed S; Sabouni A; Providencia R; Atallah E; Qintar M; Chico TJ
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD005154. PubMed ID: 29025197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia.
    Smith GD; Fry MM; Taylor D; Morgans A; Cantwell K
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD009502. PubMed ID: 25922864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.
    Kleinman ME; de Caen AR; Chameides L; Atkins DL; Berg RA; Berg MD; Bhanji F; Biarent D; Bingham R; Coovadia AH; Hazinski MF; Hickey RW; Nadkarni VM; Reis AG; Rodriguez-Nunez A; Tibballs J; Zaritsky AL; Zideman D;
    Pediatrics; 2010 Nov; 126(5):e1261-318. PubMed ID: 20956433
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.